Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cytokinetics (CYTK) Return on Sales: 2009-2025

Historic Return on Sales for Cytokinetics (CYTK) over the last 16 years, with Sep 2025 value amounting to -7.06%.

  • Cytokinetics' Return on Sales rose 16708.00% to -7.06% in Q3 2025 from the same period last year, while for Sep 2025 it was -7.06%, marking a year-over-year increase of 16708.00%. This contributed to the annual value of -38.26% for FY2024, which is 3139.00% up from last year.
  • Latest data reveals that Cytokinetics reported Return on Sales of -7.06% as of Q3 2025, which was down 3.13% from -6.85% recorded in Q2 2025.
  • Cytokinetics' 5-year Return on Sales high stood at -1.29% for Q2 2022, and its period low was -174.14% during Q3 2024.
  • Over the past 3 years, Cytokinetics' median Return on Sales value was -51.23% (recorded in 2023), while the average stood at -69.26%.
  • Per our database at Business Quant, Cytokinetics' Return on Sales plummeted by 13,628bps in 2024 and then surged by 16,708bps in 2025.
  • Over the past 5 years, Cytokinetics' Return on Sales (Quarterly) stood at -2.91% in 2021, then plummeted by 72bps to -3.63% in 2022, then tumbled by 6,602bps to -69.66% in 2023, then spiked by 3,497bps to -34.69% in 2024, then surged by 16,708bps to -7.06% in 2025.
  • Its Return on Sales stands at -7.06% for Q3 2025, versus -6.85% for Q2 2025 and -34.48% for Q1 2025.